skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz Paulo M Hoff; Jeffrey S Morris; Robert A Wolff; Cathy Eng; Katrina Y Glover; Rosie Adinin; Michael J Overman; Vincete Valero; Sijin Wen; Christopher Lieu; Shaoyu Yan; Hai T Tran; Lee M Ellis; James L Abbruzzese; John V Heymach

Journal of Clinical Oncology New York v. 28, n. 3, p. 453-459, 2010

New York 2010

Acesso online. A biblioteca também possui exemplares impressos.

2
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz Paulo M Hoff; Jeffrey S Morris; Robert A Wolff; Cathy Eng; Katrina Y Glover; Rosie Adinin; Michael J Overman; Vincete Valero; Sijin Wen; Christopher Lieu; Shaoyu Yan; Hai T Tran; Lee M Ellis; James L Abbruzzese; John V Heymach

Journal of Clinical Oncology New York v. 28, n. 3, p. 453-459, 2010

New York 2010

Acesso online. A biblioteca também possui exemplares impressos.

3
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia J. Scarisbrick H. Miles Prince; Maarten H Vermeer; Pietro Quaglino; Steven Horwitz; Pierluigi Porcu; Rudolf Stadler; Gary S Wood; Marie Beylot-Barry; Anne Pham-Ledard; Francine Foss; Michael Girardi; Martine Bagot; Laurence Michel; Maxime Battistella; Joan Guitart; Timothy M Kuzel; Maria Estela Martinez-Escala; Teresa Estrach; Evangelia Papadavid; Christina Antoniou; Dimitis Rigopoulos; Vassilki Nikolaou; Makoto Sugaya; Tomomitsu Miyagaki; Robert Gniadecki; José Antonio Sanches; Jade Cury-Martins; Denis Miyashiro; Octavio Servitje; Cristina Muniesa; Emilio Berti; Francesco Onida; Laura Corti; Emilia Hodak; Iris Amitay-Laish; Pablo L Ortiz-Romero; Jose L Rodríguez-Peralto; Robert Knobler; Stefanie Porkert; Wolfgang Bauer; Nicola Pimpinelli; Vieri Grandi; Richard Cowan; Alain Rook; Ellen Kim; Alessandro Pileri; Annalisa Patrizi; Ramon M Pujol; Henry Wong; Kelly Tyler; Rene Stranzenbach; Christiane Querfeld; Paolo Fava; Milena Maule; Rein Willemze; Felicity Evison; Stephen Morris; Robert Twigger; Rakhshandra Talpur; Jinah Kim; Grant Ognibene; Shufeng Li; Mahkam Tavallaee; Richard T Hoppe; Madeleine Duvic; Sean J Whittaker; Youn H Kim

Journal of Clinical Oncology New York v. 33, n. 32, p. 3766-3773, 2015

New York 2015

Acesso online. A biblioteca também possui exemplares impressos.

4
Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer
Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

MORRIS, Luc G. T ; SIKORA, Andrew G ; PATEL, Snehal G ; HAYES, Richard B ; GANLY, Ian

Journal of clinical oncology, 2011-02, Vol.29 (6), p.739-746 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors

MCLAUGHLIN, Sarah A ; WRIGHT, Mary J ; MORRIS, Katherine T ; SAMPSON, Michelle R ; BROCKWAY, Julia P ; HURLEY, Karen E ; RIEDEL, Elyn R ; VAN ZEE, Kimberly J

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5220-5226 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

DE GEEST, Koen ; BLESSING, John A ; MORRIS, Robert T ; DIANE YAMADA, S ; MONK, Bradley J ; ZWEIZIG, Susan L ; MATEI, Daniela ; MULLER, Carolyn Y ; RICHARDS, William E

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
7
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study

Copeland, Larry J ; Brady, Mark F ; Burger, Robert A ; Rodgers, William H ; Huang, Helen Q ; Cella, David ; O'Malley, David M ; Street, Daron G ; Tewari, Krishnansu S ; Bender, David P ; Morris, Robert T ; Lowery, William J ; Miller, David S ; Dewdney, Summer B ; Spirtos, Nick M ; Lele, Shashikant B ; Guntupalli, Saketh ; Ueland, Frederick R ; Glaser, Gretchen E ; Mannel, Robert S ; DiSaia, Philip J

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4119-4128 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
8
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)

Ho, Alan L ; Foster, Nathan R ; Zoroufy, Alex J ; Campbell, Jordan D ; Worden, Francis ; Price, Katharine ; Adkins, Douglas ; Bowles, Daniel W ; Kang, Hyunseok ; Burtness, Barbara ; Sherman, Eric ; Morton, Roscoe ; Morris, Luc G T ; Nadeem, Zaineb ; Katabi, Nora ; Munster, Pamela ; Schwartz, Gary K

Journal of clinical oncology, 2022-12, Vol.40 (36), p.4240-4249 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
9
Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC)
Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC)

Nelson, J. B. ; Fizazi, K. ; Miller, K. ; Higano, C. S. ; Moul, J. W. ; Morris, T. ; McIntosh, S. ; Pemberton, K. ; Gleave, M. E.

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.117-117 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Phase I study of the specific endothelin A receptor antagonist zibotentan (ZD4054) combined with docetaxel in patients with metastatic castration-resistant prostate cancer: Assessment of efficacy, pain, and safety
Phase I study of the specific endothelin A receptor antagonist zibotentan (ZD4054) combined with docetaxel in patients with metastatic castration-resistant prostate cancer: Assessment of efficacy, pain, and safety
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study of the specific endothelin A receptor antagonist zibotentan (ZD4054) combined with docetaxel in patients with metastatic castration-resistant prostate cancer: Assessment of efficacy, pain, and safety

Trump, D. L. ; Payne, H. ; Miller, K. ; De Bono, J. S. ; Stephenson, J. ; Burris, H. A. ; Nathan, F. E. ; Taboada, M. ; Morris, T. ; Hübner, A.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4664-4664 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (56)
  2. 2010Até2012  (138)
  3. 2013Até2015  (190)
  4. 2016Até2019  (259)
  5. Após 2019  (235)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Glover, K
  2. Wen, S
  3. Lieu, C
  4. Overman, M
  5. Adinin, R

Neste Assunto:

  1. Oncology
  2. Life Sciences & Biomedicine
  3. Science & Technology
  4. Humans
  5. Male

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.